These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 8837846)

  • 21. Use of benchmark dose and meta-analysis to determine the most sensitive endpoint for risk assessment for dimethoate.
    Reiss R; Gaylor D
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):55-65. PubMed ID: 16099569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health assessment of phosgene: approaches for derivation of reference concentration.
    Gift JS; McGaughy R; Singh DV; Sonawane B
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pharmaceuticals in US surface waters: a human health risk assessment.
    Schwab BW; Hayes EP; Fiori JM; Mastrocco FJ; Roden NM; Cragin D; Meyerhoff RD; D'Aco VJ; Anderson PD
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):296-312. PubMed ID: 15979221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods for deriving pesticide aquatic life criteria.
    TenBrook PL; Tjeerdema RS; Hann P; Karkoski J
    Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
    Dieter HH
    Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monomethylarsonic acid and dimethylarsinic acid: developmental toxicity studies with risk assessment.
    Irvine L; Boyer IJ; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):53-68. PubMed ID: 16496296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral (drinking water) two-generation reproductive toxicity study of dibromoacetic acid (DBA) in rats.
    Christian MS; York RG; Hoberman AM; Frazee J; Fisher LC; Brown WR; Creasy DM
    Int J Toxicol; 2002; 21(4):237-76. PubMed ID: 12171628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research strategy for developing key information on bromate's mode of action.
    Bull RJ; Cottruvo JA
    Toxicology; 2006 Apr; 221(2-3):135-44. PubMed ID: 16298034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicological relevance of pharmaceuticals in drinking water.
    Bruce GM; Pleus RC; Snyder SA
    Environ Sci Technol; 2010 Jul; 44(14):5619-26. PubMed ID: 20575537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health implications of nitrate and nitrite in drinking water: an update on methemoglobinemia occurrence and reproductive and developmental toxicity.
    Fan AM; Steinberg VE
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):35-43. PubMed ID: 8628918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of noncancer risk assessment approaches for use in deriving drinking water criteria.
    Gibson MC; deMonsabert SM; Orme-Zavaleta J
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):243-56. PubMed ID: 9441915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
    Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
    Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative review of the pharmacokinetics of boric acid in rodents and humans.
    Murray FJ
    Biol Trace Elem Res; 1998; 66(1-3):331-41. PubMed ID: 10050928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
    Cunningham VL; Binks SP; Olson MJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicity of boron to rainbow trout: a weight-of-the-evidence assessment.
    Loewengart G
    Environ Toxicol Chem; 2001 Apr; 20(4):796-803. PubMed ID: 11345456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-based screening levels to evaluate U.S. Geological Survey ground water quality data.
    Toccalino PL; Norman JE
    Risk Anal; 2006 Oct; 26(5):1339-48. PubMed ID: 17054535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating perchlorate exposure from food and tap water based on US biomonitoring and occurrence data.
    Huber DR; Blount BC; Mage DT; Letkiewicz FJ; Kumar A; Allen RH
    J Expo Sci Environ Epidemiol; 2011; 21(4):395-407. PubMed ID: 20571527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects assessment: boron compounds in the aquatic environment.
    Schoderboeck L; Mühlegger S; Losert A; Gausterer C; Hornek R
    Chemosphere; 2011 Jan; 82(3):483-7. PubMed ID: 21055789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.